Claritev Corp's fundamentals are relatively weak, and its growth potential is high.Its valuation is considered fairly valued, ranking 68/156 in the Professional & Commercial Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 88.33.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Claritev Corp's Score
Industry at a Glance
Industry Ranking
68 / 156
Overall Ranking
163 / 4568
Industry
Professional & Commercial Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
3
analysts
Buy
Current Rating
88.333
Target Price
+167.84%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Claritev Corp Highlights
StrengthsRisks
Claritev Corp, formerly MultiPlan Corporation, is a healthcare technology, data and insights company. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The Company uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. It uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. It provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 930.62M.
Undervalued
The company’s latest PE is -2.00, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 17.38M shares, decreasing 1.37% quarter-over-quarter.
Claritev Corp, formerly MultiPlan Corporation, is a healthcare technology, data and insights company. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The Company uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. It uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. It provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
Ticker SymbolCTEV
CompanyClaritev Corp
CEODalton (Travis S)
Websitehttps://www.claritev.com/
FAQs
What is the current price of Claritev Corp (CTEV)?
The current price of Claritev Corp (CTEV) is 42.670.
What is the symbol of Claritev Corp?
The ticker symbol of Claritev Corp is CTEV.
What is the 52-week high of Claritev Corp?
The 52-week high of Claritev Corp is 74.070.
What is the 52-week low of Claritev Corp?
The 52-week low of Claritev Corp is 5.610.
What is the market capitalization of Claritev Corp?
The market capitalization of Claritev Corp is 704.46M.
What is the net income of Claritev Corp?
The net income of Claritev Corp is -1.65B.
Is Claritev Corp (CTEV) currently rated as Buy, Hold, or Sell?
According to analysts, Claritev Corp (CTEV) has an overall rating of Buy, with a price target of 88.333.
What is the Earnings Per Share (EPS TTM) of Claritev Corp (CTEV)?
The Earnings Per Share (EPS TTM) of Claritev Corp (CTEV) is -20.916.